Request a document copy: Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial

all files (of this document) in restricted access
the file(s) you requested
Cancel